
Pharma teams covering ASCO, ESMO, ASH and other congresses face thousands of abstracts in a few days; this guide explains how AI conference intelligence platforms such as ConfXcel organise that coverage into searchable insight.
Medical congresses now produce more data in a single week than
most pharma teams can read in a month. ESMO 2025 alone accepted 2,926
abstracts, and the 2025 ASH Annual Meeting reported more than 8,200 accepted
abstracts. AI conference intelligence platforms, including ConfXcel from
XceliSys Consulting, are built to turn that volume into briefings, summaries
and a searchable record that several teams can share.
Key takeaways
●
Major congresses
are large and growing: ESMO 2025 drew 35,676 attendees, up from 33,830 the year
before.
●
Congress coverage
works in three stages: preparation before the meeting, fast summaries during it
and a searchable archive after it.
●
Field notes,
recordings and interviews carry context that public abstracts do not, so they
belong in the same record.
●
Competitive
Intelligence, Medical Affairs, Market Access and Commercial teams read congress
data differently, but all of them benefit from one shared source.
●
Security matters:
ask any vendor how data is encrypted, who can access it and what is logged.

Why medical congress coverage
has become so hard
The first challenge is scale. According to the European Medical
Journal's review of the meeting, ESMO Congress 2025 in Berlin, held from 17 to
21 October 2025, had 35,676 attendees, an all-time high. It received 5,677
abstracts and accepted 2,926 for presentation.
Haematology shows the same pattern. The 2025 ASH Annual Meeting in
Orlando, held from 6 to 9 December 2025, drew more than 30,000 attendees and
more than 8,200 accepted abstracts, according to the UF Health Cancer
Institute.
Oncology's largest meeting is no smaller. The 2025 ASCO Annual
Meeting ran from 30 May to 3 June at McCormick Place in Chicago and featured
more than 200 sessions, according to UChicago Medicine. Single institutions
bring large volumes too: Mayo Clinic said it had 59 Mayo Clinic-authored
abstracts at the meeting.
For a pharma team tracking one therapeutic area, each of these
numbers means hours of reading, cross-checking and writing. Most of that work
happens under time pressure, while the congress is still running and leaders
are asking what the new data means.
The old way: scattered notes
and spreadsheets
ConfXcel's website says its founding team spent more than a decade
working with global biopharma organisations on portfolio strategy, business
development and competitive positioning, including coverage of major medical
congresses. In that work, the company says, it saw coverage depend on manual
notes, fragmented spreadsheets and large analyst teams, with insights often
arriving too late to be useful.
This way of working creates three practical problems. Insights
stay with the person who wrote them. Different teams write their own versions
of the same session. And when a question comes up six months later, nobody can
easily find what was said, or who said it.
A single shared source solves much of this. When every team works
from the same record, a field note on a poster discussion sits next to the
abstract it refers to, and a market access lead can check the same data the
competitive intelligence analyst used.
How AI conference intelligence
works in three stages
Every congress follows a clear cycle, and good coverage follows it
too. ConfXcel, an AI[1] conference
intelligence platform for pharma,
describes its service in three stages.
●
Before the
congress: briefings on chosen therapeutic areas and competitors, so teams
arrive knowing which sessions matter.
●
During the
congress: presentation summaries, extraction of key endpoints and daily updates
while sessions are still running.
●
After the
congress: a searchable archive that tracks therapies and data over time, plus
transcription of field recordings.
The company says the platform covers ASCO, ASH, EHA, ESMO, AACR
and other major congresses. The archive stage becomes more useful every year.
With a searchable record, a team can compare how a therapy's data has changed
from one meeting to the next, without rebuilding old summaries by hand.
Adding field intelligence to
public data
Public abstracts and slides are only part of the picture. Much of
the useful context at a congress comes from conversations at posters, questions
after talks and interviews with experts.
ConfXcel says teams can upload their own field notes, recordings
and interviews, which are transcribed and stored alongside public congress
material. In practice, an off-script comment from a session can then turn up in
the same search as the abstract it relates to.
Whatever tool a team uses, the habit is simple. Capture field
observations the same day, tag them to the session or product they relate to,
and store them where colleagues can search them. Notes kept in personal files
are rarely used again.
One source for four teams
Congress data serves several functions, and each asks different
questions. According to the company, ConfXcel is built for four teams that
commonly work from congress coverage.
●
Competitive
Intelligence: tracking rival programmes, trial readouts and how new data
positions products within a therapeutic area.
●
Medical Affairs:
following the scientific discussion, expert views and remaining evidence gaps.
●
Market Access:
watching the endpoints and outcomes that may matter in later value and
reimbursement discussions.
●
Commercial:
understanding how new data may shape conversations with clinicians.
With one shared source, two teams discussing the same trial start
from the same facts. Nobody has to rebuild a summary a colleague has already
written, and disagreements become about interpretation, not about what was
presented.
Security questions to ask any
vendor
Congress coverage often mixes public data with confidential field
notes and internal strategy. Any platform that stores this material needs clear
security controls.
ConfXcel states that its platform uses AES-256 encryption at rest
and TLS 1.2 or higher in transit. The company also describes its setup as SOC 2
Type 2 aligned and SSO ready, with role-based access and audit trails. Buyers
with strict requirements should ask any vendor for the documentation that
matches their own policies. Useful questions include:
●
How is data
encrypted at rest and in transit?
●
Who can see which
records, and can access be limited by role?
●
Is every access
and change recorded in an audit trail?
●
Does the platform
support single sign-on with the company's identity system?
●
What independent
audits or reports can the vendor share?
Planning coverage for the next
congress
Good coverage starts weeks before the meeting. A simple plan helps
teams avoid gaps and duplicated work.
●
Agree on the
therapeutic areas, products and competitors that matter most.
●
Assign owners for
key sessions, posters and expert conversations.
●
Decide how and
where field notes will be shared each day.
●
Set a daily
deadline for summaries so leaders see updates while the congress is still
running.
●
After the meeting,
review what was captured and add it to the long-term archive.
Tools can speed up each step, but the plan decides what gets
captured. Teams that agree on priorities early get more value from any platform
they use.
What the changing oncology
agenda means for congress teams
The topics on congress programmes are changing as well. At the
opening of ESMO 2025, the congress's 50th year, AI and digital oncology were
key discussion topics, and ESMO planned to release a framework for using large
language models in clinical practice, according to pharmaphorum.
The same coverage noted presidential sessions featuring data from
Japan and China, and a new generation of antibody-drug conjugates being shown
to affect patients with early-stage cancer. For congress teams, more countries
and more drug classes mean more sessions to watch and more data to compare.
Planning windows are already open. The 68th ASH Annual Meeting is
scheduled for 12 to 15 December 2026 in New Orleans and online, according to
the American Society of Hematology, so teams can start briefings well before
the first session.
Frequently asked questions
What is a medical congress intelligence platform?
It is a tool that collects, summarises and stores information from
medical congresses so pharma and biotech teams can find it quickly. It usually
covers preparation before the meeting, summaries during it and an archive
afterwards.
Which congresses does ConfXcel cover?
The company says ConfXcel covers ASCO, ASH, EHA, ESMO, AACR and
other major congresses. Teams should check the current list before planning
their coverage.
Can teams add their own notes and recordings?
Yes, according to the company. Field notes, recordings and
interviews can be uploaded, transcribed and stored next to public congress
data.
How large are today's major congresses?
ESMO 2025 had 35,676 attendees and accepted 2,926 abstracts,
according to the European Medical Journal. The 2025 ASH Annual Meeting drew
more than 30,000 attendees and had more than 8,200 accepted abstracts,
according to the UF Health Cancer Institute.
About ConfXcel
ConfXcel is an AI-powered conference intelligence platform
developed by XceliSys Consulting, which the company says is based in Gurugram,
India. It gives pharma and biotech teams pre-conference briefings, daily
presentation summaries and a searchable archive of medical congress coverage,
and lets them add their own field notes, recordings and interviews. Website:
real-time
competitive intelligence pharma